JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes

alexandrossfakianakis shared this article with you from Inoreader JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes Via Blood Cancer Journal - Issue - nature.com science feeds Blood Cancer Journal, Published online: 08 April 2022; doi:10.1038/s41408-022-00646-0 JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.